Current clinical management of dysfunctional bioprosthetic pulmonary valves

Varun Aggarwal, Zachary A. Spigel, Gurumurthy Hiremath, Ziyad Binsalamah, Athar M. Qureshi

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Introduction: As with any bioprosthetic valve, bioprosthetic valves in the pulmonary position have a finite life span and patients with bioprosthetic pulmonary valves require lifetime management to treat valve dysfunction. Areas covered: In this article, authors discuss the current medical management for the treatment of dysfunctional bioprosthetic valves. This review is based on both an extensive review of the recent cardiac surgical/interventional cardiology literature (PubMed and MEDLINE database searches from 1958 to 2019) and personal experience. Expert opinion: Valve technology is rapidly progressing and with a coordinated effort from cardiac surgeons and interventional cardiologists, patients suffering from bioprosthetic pulmonary valve dysfunction can expect to have a decreased number of procedures and less invasive procedures over their lifetime now.

Original languageEnglish (US)
Pages (from-to)7-16
Number of pages10
JournalExpert review of cardiovascular therapy
Issue number1
StatePublished - Jan 2 2020

Bibliographical note

Publisher Copyright:
© 2020, © 2020 Informa UK Limited, trading as Taylor & Francis Group.


  • Bioprosthetic
  • intentional frame fracture
  • pulmonary valve
  • surgical bioprosthetic pulmonary valve placement
  • transcatheter pulmonary valve

PubMed: MeSH publication types

  • Journal Article
  • Review

Fingerprint Dive into the research topics of 'Current clinical management of dysfunctional bioprosthetic pulmonary valves'. Together they form a unique fingerprint.

Cite this